Delhi HC seeks Centre’s response on delay in safety review of acidity drug Ranitidine
Hindustan Times

In his petition, Jain contended that the safety of Ranitidine remained an
unresolved concern since September 2019
Hindustan Times

In his petition, Jain contended that the safety of Ranitidine remained an
unresolved concern since September 2019
Several outlets reported this. AI can compare where they agree and differ.
Hindustan Times
The Union ministry of health and family welfare has proposed immediately suspending licences of those drug manufacturers whose products were classified as “not of standard quality” (NSQ) after failing to meet certain specified parameters
EconomyLiveMint
Red Bull's matter has been listed for a hearing in January, along with petitions filed by other beverage companies, including PepsiCo India, Reliance Consumer, and Monster Energy India, challenging FSSAI’s action against the use of energy drink description.
EconomyLiveMint
The court said companies must show that the dispute has a genuine connection with Delhi.
IndiaThe Hindu
The Supreme Court asked the Centre and States to file status reports on setting up special courts for NDPS Act cases.
IndiaHindustan Times
The Delhi HC ordered subject experts to review four disputed answers in the UGC-NET June 2026 answer key within three weeks.
TechnologyLiveMint
The DCGI ordered the halt in production and recall of obeticholic acid tablets following similar global regulatory actions.
IndiaLiveMint
The Centre plans to upgrade high-performing Jan Aushadhi Kendras into modern flagship outlets with a better drug portfolio, redesigned store layouts and enhanced credit facilities